lapatinib 250 MG Oral Tablet [Tykerb]

RxCUI: 672152
RxNorm name: lapatinib 250 MG Oral Tablet [Tykerb]
Display name: lapatinib 250 MG Oral Tablet [Tykerb]
Full name: lapatinib 250 MG Oral Tablet [Tykerb]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TYKERB	LAPATINIB	Novartis Pharmaceuticals Corporation	eee37f88-ec6a-4c30-b8aa-e2c71f93088c	2026-01-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 672152

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
eee37f88-ec6a-4c30-b8aa-e2c71f93088c	lapatinib 250 MG Oral Tablet [Tykerb]	SBD	14	These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007	20260127
eee37f88-ec6a-4c30-b8aa-e2c71f93088c	Tykerb 250 MG Oral Tablet	SY	14	These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007	20260127
eee37f88-ec6a-4c30-b8aa-e2c71f93088c	Tykerb 250 MG Oral Tablet	PSN	14	These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007	20260127